Benign prostatic hyperplasia—also called BPH—is a condition in men in which the prostate gland is enlarged and not cancerous. It can lead to lower urinary tract symptoms (LUTS). BPH affects about 50% of men between the ages of 51 and 60 and up to 90% of men older than 80.1
Prostatic Artery Embolization (PAE) is a minimally invasive option to treat BPH and can be performed via radial or femoral access.
Terumo Interventional Systems is equipped to support your PAE procedures from access to embolization.
Keep your patients in mind as you embolize. The unique formulation of HydroPearl Microspheres was exclusively developed to offer controlled and targeted embolization. HydroPearl Microspheres are tightly calibrated and indicated for embolization of prostatic arteries (PAE) for symptomatic BPH. This precise calibration may allow more predictable and targeted embolization.2-4
Watch the video below to see how the precise engineering of HydroPearl can make a difference in your procedures:
- VuMedi Webinar: Access and Equpiment Options for PAE-Clinical Case Reviews
Learn more about Terumo's full portfolio of embolization solutions
- Urology Health. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph). Accessed 29 July 2020.
- Per Instructions For Use PD111835 Rev. B 2020-02.
- Data on file.
- Karolin J. Paprottka et al In-vitro-study of physical properties of various embolization particles regarding morphology before, during and after catheter passage. Clinical Hemorheology and Microcirculation. 1386-0291/16.